|
Aug 12
|
USNA vs. STVN: Which Stock Is the Better Value Option?
|
|
Aug 5
|
Stevanato Group (STVN) Q2 Earnings and Revenues Beat Estimates
|
|
Aug 5
|
Stevanato: Q2 Earnings Snapshot
|
|
Aug 5
|
Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025
|
|
Aug 4
|
Stevanato Group S.p.A.'s (NYSE:STVN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
|
|
Jul 25
|
MKKGY or STVN: Which Is the Better Value Stock Right Now?
|
|
Jul 25
|
Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock?
|
|
Jul 23
|
Will Escalating Medical Costs Dampen Centene's Q2 Earnings?
|
|
Jul 23
|
Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.
|
|
Jul 22
|
Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025
|
|
Mar 11
|
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
|
|
Feb 24
|
Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
|
|
Feb 23
|
Stevanato Group S.p.A. (STVN): the Most Oversold Pharma Stock to Buy According to Analysts
|
|
Feb 13
|
Is Stevanato Group S.p.A. (STVN) the Best Italian Stock to Buy in 2025?
|
|
Oct 4
|
CPRX or STVN: Which Is the Better Value Stock Right Now?
|
|
Oct 1
|
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan
|
|
Sep 30
|
Is Stevanato Group S.p.A. (STVN) the Top Italian Stock for Biopharma Investors?
|
|
Sep 12
|
Here’s What Weighed on Stevanato Group S.p.A.’s (STVN) Results
|
|
Sep 11
|
Should You Hold Stevanato Group S.p.A. (STVN)?
|
|
Aug 29
|
Stevanato Group to Present at Upcoming Investor Conferences
|